IL-13 production by regulatory T cells protects against experimental autoimmune encephalomyelitis independently of autoantigen

Journal of Immunology

Volumn 181, Issue 2, 2008, Pages 954-968

  Ochoa Repáraz, Javier ^a,c   Rynda, Agnieszka ^a   Ascón, Miguel A ^b   Yang, Xinghong ^a   Kochetkova, Irina ^a   Riccardi, Carol ^a   Callis, Gayle ^a   Trunkle, Theresa ^a   Pascual, David W ^a  

^a MONTANA STATE UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AP 331; AUTOANTIGEN; BACTERIAL VECTOR; GAMMA INTERFERON; H 647; H 696; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 21; PROTEOLIPID PROTEIN; SALMONELLOSIS VACCINE; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; COLONIZATION FACTOR ANTIGENS; CYTOKINE; FIMBRIA PROTEIN;

ADOPTIVE TRANSFER; ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL TRANSFER; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; FIMBRIA; IN VIVO STUDY; INTRACELLULAR SPACE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTECTION; PROVOCATION TEST; REGULATORY T LYMPHOCYTE; SALMONELLA; SWISS JAMES LAMBERT MOUSE; TH2 CELL; VACCINATION; ANIMAL; IMMUNOLOGY; METABOLISM;

ADOPTIVE TRANSFER; ANIMALS; AUTOANTIGENS; CD4-POSITIVE T-LYMPHOCYTES; CYTOKINES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; FIMBRIAE PROTEINS; INTERFERON TYPE II; INTERLEUKIN-13; MICE; SALMONELLA VACCINES; T-LYMPHOCYTES, REGULATORY; TH2 CELLS;

EID: 49049106824     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.2.954     Document Type: Article

References (54)

1. Sztein, M. B. 2007. Cell-mediated immunity and antibody responses elicited by attenuated Salmonella enterica serovar Typhi strains used as live oral vaccines in humans. Clin. Infect. Dis. 45: S15-S19.
2. Pascual, D. W., J. Ochoa-Repáraz, A. Rynda, and X. Yang. 2007. Tolerance in the absence of auto-antigen. Endocr. Metab. Immune Disord. Drug Targets. 7: 203-210.
3. Mastroeni, P., B. Villarreal-Ramos, and C. E. Hormaeche. 1992. Role of T cells, TNF-α and IFN-γ in recall of immunity to oral challenge with virulent salmonellae in mice vaccinated with live attenuated aro-Salmonella vaccines. Microb. Pathog. 13: 477-491.
4. + Th2 cells producing IL-6 and IL-10 are associated with mucosal immunoglobulin A responses. Infect. Immun. 64: 1516-1525.
5. VanCott, J. L., H. F. Staats, D. W. Pascual, M. Roberts, S. N. Chatfield, M. Yamamoto, M. Coste, P. B. Carter, H. Kiyono, and J. R. McGhee. 1996. Regulation of mucosal and systemic antibody responses by T helper cell subsets, macrophages, and derived cytokines following oral immunization with live recombinant Salmonella. J. Immunol. 156: 1504-1514.
6. Pascual, D. W., D. M. Hone, S. Hall, F. W. van Ginkel, M. Yamamoto, N. Walters, K. Fujihashi, R. J. Powell, S. Wu, J. L. Vancott, et al. 1999. Expression of recombinant enterotoxigenic Escherichia coli colonization factor antigen I by Salmonella typhimurium elicits a biphasic T helper cell response. Infect. Immun. 67: 6249-6256.
7. Pascual, D. W., T. Trunkle, and J. Sura. 2002. Fimbriated Salmonella enterica serovar Typhimurium abates initial inflammatory responses by macrophages. Infect. Immun. 70: 4273-4281.
8. Sospedra, M., and R. Martin. 2005. Immunology of multiple sclerosis. Annu. Rev. Immunol. 23: 683-747.
9. McFarland, H. F., and R. Martin. 2007. Multiple sclerosis: a complicated picture of autoimmunity. Nat. Immunol. 8: 913-919. (Pubitemid 47300005)
10. Juedes, A. E., P. Hjelmstrom, C. M. Bergman, A. L. Neild, and N. H. Ruddle. 2000. Kinetics and cellular origin of cytokines in the central nervous system: insight into mechanisms of myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis. J. Immunol. 164: 419-426.
11. Karpus, W. J., and R. M. Ransohoff. 1998. Chemokine regulation of experimental autoimmune encephalomyelitis: temporal and spatial expression patterns govern disease pathogenesis. J. Immunol. 161: 2667-2671.
12. Bettelli, E., Y. Carrier, W. Gao, T. Korn, T. B. Strom, M. Oukka, H. L. Weiner, and V. K. Kuchroo. 2006. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441: 235-238.
13. Nurieva, R., X. O. Yang, G. Martinez, Y. Zhang, A. D. Panopoulos, L. Ma, K. Schluns, Q. Tian, S. S. Watowich, A. M. Jetten, and C. Dong. 2007. Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature 448: 480-483. (Pubitemid 47123514)
14. Korn, T., E. Bettelli, W. Gao, A. Awasthi, S. Jäger, T. B. Strom, M. Oukka, and V. K. Kuchroo. 2007. IL-21 initiates an alternative pathway to induce proinflammatory TH17 cells. Nature 448: 484-487. (Pubitemid 47123515)
15. Bettelli, E., T. Korn, and V. K. Kuchroo. 2007. Th17: the third member of the effector T cell trilogy. Curr. Opin. Immunol. 19: 652-657. (Pubitemid 350236805)
16. H-17 cells in relapsing EAE. Nat. Immunol. 8: 172-180.
17. Veldhoen, M., R. J. Hocking, C. J. Atkins, R. M. Locksley, and B. Stockinger. 2006. TGFβ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24: 179-189. (Pubitemid 43214587)
18. Jun, S., W. Gilmore, G. Callis, A. Rynda, A. Haddad, and D. W. Pascual. 2005. A live diarrheal vaccine imprints a Th2 cell bias and acts as an anti-inflammatory vaccine. J. Immunol. 175: 6733-6740. (Pubitemid 41598917)
19. Ochoa-Repáraz, J., C. Riccardi, A. Rynda, S. Jun, G. Callis, and D. W. Pascual. 2007. Regulatory T cell vaccination without autoantigen protects against experimental autoimmune encephalomyelitis. J. Immunol. 178: 1791-1799. (Pubitemid 46154651)
20. Wu, S., D. W. Pascual, J. L. VanCott, J. R. McGhee, D. R. Maneval, Jr., M. M. Levine, and D. M. Hone. 1995. Immune responses to novel Escherichia coli and Salmonella typhimurium vectors that express colonization factor antigen I (CFA/I) of enterotoxigenic E. coli in the absence of the CFA/I positive regulator cfaR. Infect. Immun. 63: 4933-4938.
21. Sakellaris, H., G. P. Munson, and J. R. Scott. 1999. A conserved residue in the tip proteins of CS1 and CFA/I pili of enterotoxigenic Escherichia coli that is essential for adherence. Proc. Natl. Acad. Sci. USA 96: 12828-12832. (Pubitemid 29513587)
22. Yang, X., B. J. Hinnebusch, T. Trunkle, C. M. Bosio, Z. Suo, M. Tighe, A. Harmsen, T. Becker, K. Crist, N. Walters, et al. 2007. Oral vaccination with Salmonella simultaneously expressing Yersinia pestis F1 and V antigens protects against bubonic and pneumonic plague. J. Immunol. 178: 1059-1067. (Pubitemid 46095179)
23. Ascón, M. A., J. Ochoa-Repáraz, N. Walters, and D. W. Pascual. 2005. Partially assembled K99 fimbriae required for protection. Infect. Immun. 73: 7274-7280. (Pubitemid 41587626)
24. Pascual, D. W., M. White, T. Larson, and N. Walters. 2001. Impaired mucosal immunity in L-selectin-deficient mice orally immunized with a Salmonella vaccine vector. J. Immunol. 167: 407-415.
25. Lakkis, F. G., E. N. Cruet, G. M. Nassar, K. F. Badr, and D. W. Pascual. 1997. Expression of recombinant rat interleukin-13 and generation of a neutralizing rat IL-13 antiserum. Biochem. Biophys. Res. Commun. 235: 529-532.
26. + Thcell- mediated alveolar bone destruction in vivo. Infect. Immun. 73: 3453-3461.
27. + T-cells trigger RANKLmediated enhanced alveolar bone loss in diabetic NOD mice. Diabetes 54: 1477-1486.
28. + regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis. J. Immunol. 169: 4712-4716.
29. + regulatory cells within the central nervous system. J. Immunol. 175: 3025-3032.
30. Yu, P., R. K. Gregg, J. J. Bell, J. S. Ellis, R. Divekar, H. H. Lee, R. Jain, H. Waldner, J. C. Hardaway, M. Collins, et al. 2005. Specific T regulatory cells display broad suppressive functions against experimental allergic encephalomyelitis upon activation with cognate antigen. J. Immunol. 174: 6772-6780. (Pubitemid 40705640)
31. Young, D. A., L. D. Lowe, S. S. Booth, M. J. Whitters, L. Nicholson, V. K. Kuchroo, and M. Collins. 2000. IL-4, IL-10, IL-13, and TGF-β from an altered peptide ligand-specific Th2 cell clone down-regulate adoptive transfer of experimental autoimmune encephalomyelitis. J. Immunol. 164: 3563-3572.
32. + immunoregulatory T cells that control autoimmune diabetes. Immunity 12: 431-440.
33. + regulatory cells that control intestinal inflammation. J. Exp. Med. 192: 295-302.
34. + naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int. Immunol. 10: 1969-1980.
35. + regulatory T-cell-mediated suppression. Immunology 118: 240-249.
36. - regulatory T cells. J. Immunol. 176: 4748-4756.
37. + regulatory T-cell development and M-cell formation inside Peyer's patches. Am. J. Pathol. 166: 1647-1654.
38. + regulatory T cells bear functional skin-homing receptors. J. Immunol. 177: 4488-4494.
39. Offner, H., S. Subramanian, C. Wang, M. Afentoulis, A. A. Vandenbark, J. Huan, and G. G. Burrows. 2005. Treatment of passive experimental autoimmune encephalomyelitis in SJL mice with a recombinant TCR ligand induces IL-13 and prevents axonal injury. J. Immunol. 175: 4103-4111. (Pubitemid 41292074)
40. Kleinschek, M. A., A. M. Owyang, B. Joyce-Shaikh, C. L. Langrish, Y. Chen, D. M. Gorman, W. M. Blumenschein, T. McClanahan, F. Brombacher, S. D. Hurst, et al. 2007. IL-25 regulates Th17 function in autoimmune inflammation. J. Exp. Med. 204: 161-170. (Pubitemid 46148766)
41. Zenewicz, L. A., G. D. Yancopoulos, D. M. Valenzuela, A. J. Murphy, M. Karow, and R. A. Flavell. 2007. Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation. Immunity 27: 647-659.
42. Kreymborg, K., R. Etzensperger, L. Dumoutier, S. Haak, A. Rebollo, T. Buch, F. L. Heppner, J. C. Renauld, and B. Becher. 2007. IL-22 is expressed by Th17 cells in an IL-23-dependent fashion, but not required for the development of autoimmune encephalomyelitis. J. Immunol. 179: 8098-8104.
43. Hofstetter, H. H., S. M. Ibrahim, D. Koczan, N. Kruse, A. Weishaupt, K. V. Toyka, and R. Gold. 2005. Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis. Cell. Immunol. 237: 123-130. (Pubitemid 43117208)
44. Komiyama, Y., S. Nakae, T. Matsuki, A. Nambu, H. Ishigame, S. Kakuta, K. Sudo, and Y. Iwakura. 2006. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J. Immunol. 177: 566-573. (Pubitemid 43939170)
45. Sutton, C., C. Brereton, B. Keogh, K. H. Mills, and E. C. Lavelle. 2006. A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis. J. Exp. Med. 203: 1685-1691. (Pubitemid 44036274)
46. Billiau, A. H., H. Heremans, F. Vandekerckhove, R. Kijkmans, I. Sobis, E. Meulepas, and H. Carton. 1988. Enhancement of experimental allergic encephalomyelitis in mice by antibodies against IFN-γ. J. Immunol. 140: 1506-1510. (Pubitemid 18103575)
47. Duong, T. T., F. D. Finkelman, B. Singh, and G. H. Strejan. 1994. Effect of anti-interferon-γ monoclonal antibody treatment on the development of experimental allergic encephalomyelitis in resistant mouse strains. J. Neuroimmunol. 53: 101-107. (Pubitemid 2125900)
48. Ferber, I. A., S. Brocke, C. Taylor-Edwards, W. Ridgway, C. Dinisco, L. Steinman, D. Dalton, and C. G. Fathman. 1996. Cutting edge: mice with a disrupted IFN-γ gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J. Immunol. 156: 5-7.
49. Chu, C. Q., S. Wittmer, and D. K. Dalton. 2000. Failure to suppress the expansion of the activated CD4 T cell population in interferon γ-deficient mice leads to exacerbation of experimental autoimmune encephalomyelitis. J. Exp. Med. 192: 123-128.
50. Willenborg, D. O., S. Fordham, C. C. Bernard, W. B. Cowden, and I. A. Ramshaw. 1996. Cutting edge: IFN-γ plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. J. Immunol. 157: 3223-3227.
51. + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6: 1123-1132.
52. Park, H., Z. Li, X. O. Yang, S. H. Chang, R. Nurieva, Y. H. Wang, Y. Wang, L. Hood, Z. Zhu, Q. Tian, and C. Dong. 2005. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6: 1133-1141. (Pubitemid 41541791)
53. Voorthuis, J. A., B. M. Uitdehaagh, C. J. DeGroot, P. H. Goede, P. H. Vander Meide, and C. D. Dijkstra. 1990. Suppression of experimental allergic encephalomyelitis by intraventricular administration of interferon-γ in Lewis rats. Clin. Exp. Immunol. 81: 183-188. (Pubitemid 20242519)
54. Espejo, C., M. Penkowa, I. Sáez-Torres, J. Xaus, A. Celada, X. Montalban, and E. M. Martinez-Cáceres. 2001. Treatment with anti-interferon-γ monoclonal antibodies modifies experimental autoimmune encephalomyelitis in interferon-γreceptor knockout mice. Exp. Neurol. 172: 460-468. (Pubitemid 34075095)